United States

People: Santander Bank Polska SA (BKZHY.PK)

BKZHY.PK on OTC Markets Group - US Other OTC and Grey Market

Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Woroszylska-Sapieha, Marynika 

Ms. Marynika Woroszylska-Sapieha has served as Independent Member of the Supervisory Board of Santander Bank Polska Spolka Akcyjna (formerly Bank Zachodni WBK S.A.) since April 16, 2014. She is Member of the Audit and Compliance Committee, the Nominating Committee and the Remuneration Committee at the Company. She graduated from Warszawski Uniwersytet Medyczny. For more than a decade she worked at the Institute of Cardiology in Anin. She also graduated from International Executive Program INSEAD in Fontainebleau. In 1994 she moved to the pharmaceutical industry. Since 1997 has been connected with Sanofi Group and at present, she performs the role of the General Manager of Sanofi Group in Poland. In her professional career, she was General Director of Sanofi-Synthelabo sp. z o.o. (2003 – 2004), Divisional Director of Sanofi-Synthelbo sp. z o.o. (1998-2003), and has also held number of managerial roles in Infa Biocom (1994-1996). In the years 2005-2012, Ms. Woroszylska-Sapieha was Management Board Member of the Association of Pharmaceutical Companies Representatives (a Polish branch of EFPIA). In October 2012, she was appointed President of the Board of INFARMA.

Basic Compensation

Total Annual Compensation, PLN 228,000
Restricted Stock Awards, PLN --
Long-Term Incentive Plans, PLN --
All Other, PLN --
Fiscal Year Total, PLN 228,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --